Literature DB >> 25528327

Anti-inflammatory effects of a triple-bond resveratrol analog: structure and function relationship.

Csenge Antus1, Balazs Radnai1, Peter Dombovari1, Fruzsina Fonai1, Peter Avar1, Peter Matyus2, Boglarka Racz1, Balazs Sumegi3, Balazs Veres4.   

Abstract

Resveratrol is a polyphenol found in grapes and red wine, showing well-characterized anti-inflammatory and antiproliferative activities. In order to exceed resveratrol׳s biological effects and to reveal the structural determinants of the molecule׳s activity, numerous derivatives were synthesized recently. Most of these resveratrol analogs vary from the original molecule in the number, position or identity of the phenolic functional groups. Investigation of the analogs provided important data regarding structure-activity relationship of the molecule. With the exception of cis- and trans-resveratrol and the reduced form dihydroresveratrol, little is known about the molecular effects of the stilbene backbone. In the present study we investigated the anti-inflammatory properties of a new, triple-bond resveratrol analog, 3,4',5-trihydroxy-diphenylacetylene (TDPA) on lipopolysaccharide-stimulated RAW macrophages. We found that the analog had weaker antioxidant activity and stronger inhibitory effect on nuclear factor-kappaB activation, and on cyclooxygenase-2, tumor necrosis factor α and interleukin-6 production. It also prevented lipopolysaccharide-induced depolarization of the mitochondrial membrane. In contrast to resveratrol, TDPA increased the phosphorylation of c-Jun N-terminal and p38 mitogen activated protein kinases. In summary, we identified a novel compound with better anti-inflammatory properties than resveratrol. Our results contributed to a better understanding of the structural determinants of resveratrol׳s biological activities.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Inflammation; Lipopolysaccharide; Macrophage; NF-kappaB; Resveratrol (PubChem CID: 445154)

Mesh:

Substances:

Year:  2014        PMID: 25528327     DOI: 10.1016/j.ejphar.2014.12.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Resveratrol and Alzheimer's Disease: Mechanistic Insights.

Authors:  Touqeer Ahmed; Sehrish Javed; Sana Javed; Ameema Tariq; Dunja Šamec; Silvia Tejada; Seyed Fazel Nabavi; Nady Braidy; Seyed Mohammad Nabavi
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

Review 2.  Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?

Authors:  Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

3.  Resveratrol Prevents Retinal Dysfunction by Regulating Glutamate Transporters, Glutamine Synthetase Expression and Activity in Diabetic Retina.

Authors:  Kaihong Zeng; Na Yang; Duozi Wang; Suping Li; Jian Ming; Jing Wang; Xuemei Yu; Yi Song; Xue Zhou; Yongtao Yang
Journal:  Neurochem Res       Date:  2015-12-16       Impact factor: 3.996

4.  Resveratrol analogue 4,4'-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis.

Authors:  Monica Savio; Daniela Ferraro; Cristina Maccario; Rita Vaccarone; Lasse D Jensen; Federica Corana; Barbara Mannucci; Livia Bianchi; Yihai Cao; Lucia Anna Stivala
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

Review 5.  Resveratrol Role in Autoimmune Disease-A Mini-Review.

Authors:  Ana Lígia de Brito Oliveira; Valter Vinicius Silva Monteiro; Kely Campos Navegantes-Lima; Jordano Ferreira Reis; Rafaelli de Souza Gomes; Dávila Valentina Silva Rodrigues; Silvia Letícia de França Gaspar; Marta Chagas Monteiro
Journal:  Nutrients       Date:  2017-12-01       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.